- Blink Topics
- Personal Tools
- Business Tools
- Instruction Tools
- Research Tools
Learn about the Institutional Biosafety Committee and see a list of its members.
Institutional Biosafety Committee (IBC) |
|
|---|---|
|
The major responsibilities of this committee include:
Read the complete committee charge. |
|
Ex officio |
Title |
| Mac Pherson, Garry | Director, Environment, Health & Safety |
| Crawford, Nigel | *Subject Matter Expert in Plant Pathogens (voting when required) |
| Friedmann, Theodore | *Subject Matter Expert in Human Gene Therapy (voting when required) |
| Daniels, Gregory | *Subject Matter Expert in Human Gene Therapy (voting when required) |
| Letendre, Scott | *Subject Matter Expert in Virology (voting when required) |
| Miyanohara, Atsushi | Director, Vector Lab (Voting) |
| Richter, Phil | Campus Veterinarian (Voting) |
| Sarmiento, Bundy | Chair, Veterans Affairs Biosafety Committee |
| Smith, Ken | Research Safety Manager |
| Torriani, Francesca | Medical Director – Infection Prevention/ Clinical Epidemiology Unit (Voting) |
| Wong, Brenda | Biological Safety Officer |
Appointed |
Title |
| Siddiqui, Aleem |
School of Medicine faculty representative knowledgeable in infectious agents and recombinant DNA |
| Joseph, Simpson | General campus faculty representative knowledgeable in infectious agents and recombinant DNA |
| Reid, Tony | General campus faculty representative knowledgeable in recombinant DNA and gene therapy |
| Aroian, Raffi |
General campus faculty representative |
| Catanzaro, Antonino | School of Medicine faculty representative |
| Rosenbach, Michael |
Staff representative |
| Peter, Christopher | Community representative |
| Bohrer, Robert | Community representative |
| Schrenzel, Mark | Community representative |
* Voting ad hoc members
The IBC is advisory to the chancellor through the vice chancellor – Resource Management and Planning on all matters relating to the safe use of hazardous biological materials and organisms. It is the committee's responsibility to establish, monitor, and enforce policies and procedures which meet or exceed applicable norms or regulations for biohazardous materials and/or recombinant DNA, including gene transfer clinical trials. Any use of biohazardous materials and/or recombinant DNA must be reviewed and approved by the committee (or the biological safety officer operating within guidelines established by the committee). The committee has the authority to impose disciplinary measures in cases where there is willful or negligent violation of UCSD's established biosafety practices and procedures. The sanctions are subject to review and/or modification by the chancellor. The committee shall maintain diverse membership representing the community and a variety of university interests. Non-committee faculty or staff with a particular expertise will be asked to advise the committee when the need arises.
